• This record comes from PubMed

Aetiology and management of persistent withdrawal occlusion in venous ports in oncology patients

. 2024 Jul-Sep ; 107 (3) : 368504241260374.

Language English Country Great Britain, England Media print

Document type Journal Article

INTRODUCTION: Persistent withdrawal occlusion (PWO) is a specific catheter malfunction characterized by the inability to withdraw blood through the device. The most common cause of PWO in ports is the presence of a fibroblastic sleeve (FS). If malfunction occurs, medication can be applied incorrectly with the increased risk of complications. METHODS: One hundred seventy-seven cases of PWO in venous ports were managed. We focused on evaluating the cause of PWO, the frequency of occurrence of FS, and the options to address the malfunction. The patients underwent fluoroscopy with a contrast agent administration. Mechanical disruption (MD) with a syringe of saline using the flush method was used; in case of its failure, subsequent administration of a lock solution with taurolidine and urokinase, or low-dose thrombolysis with alteplase was indicated. Demographic data were compared with a control group. RESULTS: A significantly higher proportion of female patients was found in the cohort of patients with PWO (80.3% vs 66.3%, p = 0.004), dominantly patients with ovarian cancer (12.8% vs 4.8%, p = 0.022). No effect of the cannulated vein or the type of treatment on the incidence of PWO was demonstrated. The presence of FS was verified in 70% of cases. MD with a syringe was successful in 53.5% of cases. A significantly shorter time to referral (3 weeks) was demonstrated with successful management. The overall success rate of achieving desobliteration by MD alone or in combination with a thrombolytic (urokinase or alteplase) administration was 97.4%. CONCLUSION: We created a method for resolving PWO using MD +/- application of thrombolytics with 97.4% success rate. Current evidence showed that FS is not likely to be affected by thrombolytic drugs; however, we have ascertained an effect of these drugs, proposing a hypothesis of microthrombotic events at the tip of the catheter if fibroblastic sleeve is present.

See more in PubMed

Lichtenstein T, Mammadov K, Rau K, et al. Long-term follow-up and clinical relevance of incidental findings of fibrin sheath and thrombosis on computed tomography scans of cancer patients with Port Catheters. Ther Clin Risk Manag 2021; 17: 111–118. PubMed PMC

Passaro G, Pittiruti M, La Greca A. The fibroblastic sleeve, the neglected complication of venous access devices: a narrative review. J Vasc Access 2021; 22: 801–813. PubMed

Xiang DZ, Verbeken EK, Van Lommel ATL, et al. Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg 1998; 28: 260–271. PubMed

Xiang DZ, Verbeken EK, Van Lommel ATL, et al. Sleeve-related thrombosis. Thromb Res 2001; 104: 7–14. PubMed

Forauer AR, Theoharis CG, Dasika NL. Jugular vein catheter placement: histologic features and development of catheter-related (fibrin) sheaths in a swine model. Radiology 2006; 240: 427–434. PubMed

Wilson CJ, Clegg RE, Leavesley DI, et al. Mediation of biomaterial–cell interactions by adsorbed proteins: a review. Tissue Eng 2005; 11: 1–18. PubMed

Wang L, Jia L, Jiang A. Pathology of catheter-related complications: what we need to know and what should be discovered. J Int Med Res 2022; 50: 030006052211278. PubMed PMC

Pittiruti M, Pelagatti F, Pinelli F. Intracavitary electrocardiography for tip location during central venous catheterization: a narrative review of 70 years of clinical studies. J Vasc Access 2021; 22: 778–785. PubMed

Capozzoli G, Accinelli G, Fabbro L, et al. Intra-cavitary ECG is an effective method for correct positioning of the tip of tunneled Groshong Catheters. J Vasc Access 2012; 13: 393–396. PubMed

Pelagatti C, Villa G, Casini A, et al. Endovascular electrocardiography to guide placement of totally implantable central venous catheters in oncologic patients. J Vasc Access 2011; 12: 348–353. PubMed

D’Arrigo S, Annetta MG, Pittiruti M. An ultrasound-based technique in the management of totally implantable venous access devices with persistent withdrawal occlusion. J Vasc Access 2023; 24: 140–144. PubMed

Iacobone E, Elisei D, Gattari D, et al. Transthoracic echocardiography as bedside technique to verify tip location of central venous catheters in patients with atrial arrhythmia. J Vasc Access 2020; 21: 861–867. PubMed

Upadhyay J, Basu S, Srivastava Y, et al. Agitated saline contrast to delineate central venous catheter position in neonates. J Perinatol 2021; 41: 1638–1644. PubMed

Wen M, Stock K, Heemann U, et al. Agitated saline bubble–enhanced transthoracic echocardiography. Crit Care Med 2014; 42: e231–e233. PubMed

Feliu J, Jiménez-Gordo AM, Madero R, et al. Development and validation of a prognostic nomogram for terminally ill cancer patients. J Nat Cancer Inst 2011; 103: 1613–1620. PubMed

Yang WJ, Song MG, Seo TS, et al. Effectiveness of mechanical recanalization for intraluminal occlusion of totally implantable venous access ports. J Vasc Access 2023; 24: 430–435. PubMed

Spencer TR, Pittiruti M. Rapid central vein assessment (raceva): a systematic, standardized approach for ultrasound assessment before central venous catheterization. J Vasc Access 2019; 20: 239–249. PubMed

Song MG, Seo TS, Kim B, et al. Mechanical recanalization for clot occlusion of venous access ports: experimental study using ports with clot occlusion. J Vasc Access 2017; 18: 158–162. PubMed

Heye S, Maleux G, Goossens GA, et al. Feasibility and safety of endovascular stripping of totally implantable venous access devices. Cardiovasc Intervent Radiol 2012; 35: 607–612. PubMed

Janne d’Othée B, Tham JC, Sheiman RG. Restoration of patency in failing tunneled hemodialysis catheters: a comparison of catheter exchange, exchange and balloon disruption of the fibrin sheath, and femoral stripping. J Vasc Interv Radiol 2006; 17: 1011–1015. PubMed

Gray RJ, Levitin A, Buck D, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning Wellpositioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol 2000; 11: 1121–1129. PubMed

Merport M, Murphy TP, Egglin TK, et al. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial. J Vasc Interv Radiol 2000; 11: 1115–1120. PubMed

Chang DH, Mammadov K, Hickethier T, et al. Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis. Ther Clin Risk Manag 2017; 13: 111–115. PubMed PMC

Massmann A, Jagoda P, Kranzhoefer N, et al. Local low-dose thrombolysis for safe and effective treatment of venous port-catheter thrombosis. Ann Surg Oncol 2015; 22: 1593–1597. PubMed

Whigham CJ, Lindsey JI, Goodman CJ, et al. Venous port salvage utilizing low dose TPA. Cardiovasc Intervent Radiol 2002; 25: 513–516. PubMed

Suojanen JN, Brophy DP, Nasser I. Thrombus on indwelling central venous catheters: the histopathology of “fibrin sheaths”. Cardiovasc Intervent Radiol 2000; 23: 194–197. PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...